Form 4: Ceribell Inc. Executive Receives Stock Grant

Ceribell, Inc. reports a significant stock grant to Chief Financial Officer Scott Blumberg, including restricted stock units and stock options.

Summary

• Scott Blumberg, Chief Financial Officer of Ceribell, Inc., received a grant of 30,736 shares of Common Stock on April 1, 2026, valued at $0.
• Additionally, Blumberg was granted a stock option to buy 51,227 shares of Common Stock at an exercise price of $18.50, with an expiration date of April 1, 2036.
• The stock option shares are subject to vesting on a quarterly anniversary from May 20, 2026, contingent upon continued employment.
• Following these transactions, Blumberg beneficially owns 149,070 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine executive compensation transactions rather than significant financial performance or strategic shifts.

Positives

• Grant of restricted stock units (RSUs) to a key executive, indicating potential long-term incentive and alignment with company performance.
• Award of stock options to the CFO, providing an opportunity for future financial gain tied to the company's stock price appreciation.
• The executive's beneficial ownership of a substantial number of shares (149,070) suggests a significant personal stake in the company's success.

Negatives

• The initial reported value of the granted common stock is $0, which may require further clarification on the valuation method or timing.
• The exercise price of the stock options ($18.50) is significantly higher than the current market price, implying substantial future stock appreciation is needed for the options to be in-the-money.

Risks

• The vesting of stock options is contingent on continued employment, posing a risk of forfeiture if the reporting person leaves the company before the vesting dates.
• The significant number of shares subject to options means that a substantial increase in the stock price is required for these options to become financially valuable, which is not guaranteed.

Future Outlook

The vesting schedule for the stock options, starting May 20, 2026, indicates a forward-looking incentive tied to continued service and potential future stock performance.

Industry Context

StockSavvy.ai notes that the granting of RSUs and stock options to key executives like the CFO is a common practice in the technology and biotech sectors to attract, retain, and incentivize talent, aligning their interests with shareholders.

Stakeholder Impact

• Shareholders: The grants may dilute ownership slightly upon exercise of options but also signal executive commitment and alignment with long-term value creation.
• Employees: May observe executive compensation practices, potentially influencing morale or retention.
• Management: Reinforces the incentive structure for the Chief Financial Officer.

Next Steps

• Continued employment of Scott Blumberg to meet vesting conditions for stock options.
• Potential exercise of stock options by Scott Blumberg on or after vesting dates, subject to market conditions and exercise price.

Key Dates

Keywords

Form 4, SEC Filing, Ceribell Inc., CBLL, Stock Grant, RSU, Stock Option, Beneficial Ownership, Executive Compensation, Scott Blumberg, CFO